ENvue Medical, Inc.
corporate_fare Company Profile
ENvue Medical, Inc. (OTC:FEED) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 28 items for FEED at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-09-15, rated 8/10. Across its 20 most recent items scored 7 or higher, the top rating is 9/10, with 13 rated 8 or above. Recent SEC coverage for FEED spans 8-K, 10-Q, PRE 14A, SCHEDULE 13D/A.
Recent high-impact activity:
- Nasdaq Denies ENvue Medical's Listing Appeal; Stock Moves to OTC
- ENvue Medical Sets 1-for-12 Reverse Split Effective September 1
- ENvue Medical Sets 1-for-12 Reverse Split to Regain Nasdaq Compliance
- ENvue Medical Inks Exclusive Uroshield Distribution Deal With $2.6M Minimum Commitments
- ENvue Medical 10-Q Quantifies $50M Equity Facility and $59M Preferred Upsizing, Warns of Going Concern
Short Interest & Short Volume
1.00 days to coverFINRA reported short interest of 23,833 shares in FEED as of the October 30, 2026 settlement, a 41.9% decrease from the prior period — about 1.0 days to cover at its recent average daily volume. On November 20, 2026, 63.0% of FEED volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.
Dilution Risk
Low riskFiling-implied dilution signals for FEED, detected from its recent SEC filings · based on capital-structure filings through 2026-08-12.
$50M Committed Equity Facility · Series H Facility Upsized to $59M
A filing-implied signal, not a realized share count. How Wiseek tracks dilution →